NASDAQ · Medical - Devices

COCH (COCH) Stock

$0.67 +1.71% NASDAQ: COCH Healthcare

Valuation

MetricValue
Price$0.67
Market Cap$14.02M
P/E Ratio-0.74
P/B Ratio4.91
P/S Ratio66.84
EPS (TTM)$0.00
52-Week High$1.89
52-Week Low$0.36
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE239.44%
ROA-77.49%
ROCE-131.29%
Gross Margin0.00%
Operating Margin0.00%
Net Margin-98.76%
Debt/Equity0.08
Current Ratio0.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-7.0M$-9.0M$-18.0M$-19.0M$-22.0M
Net Profit$-9.0M$-16.0M$-30.0M$-21.0M$-24.0M
EPS$-1.05$-1.57$-2.54$-1.49$-1.23
Op Margin-2216.4%-3673.4%-5809.8%-8558.2%-9240.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.0M$3.0M$8.0M$12.0M$9.0M
Total Liabilities$48.0M$39.0M$10.0M$30.0M$20.0M
Cash$1.0M$0$4.0M$5.0M$4.0M
Borrowings$23.0M$35.0M$1.0M$20.0M$1.0M

Latest News

Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial TMX Newsfile · Jul 21, 2026 EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant Benzinga · Jul 21, 2026 Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant TMX Newsfile · Jul 14, 2026 EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results Benzinga · Jul 14, 2026 AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates Zacks · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-9.0M$-17.0M$-18.0M$-18.0M
Investing Cash Flow$0$0$0$-2.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$0$4.0M$1.0M$-2.0M
Free Cash Flow$-7.0M$-9.0M$-17.0M$-19.0M$-18.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA0.40
FCF Yield-132.40%
Quick Ratio2.14
Interest Coverage-21.12
Return 1Y-55.88%
Return 3Y-92.94%
Return 5Y-92.52%

Ownership

Insiders Held40.50%
Institutions Held22.90%
Institutions Float Held38.50%
Institutional HolderSharesReport Date
Nantahala Capital Management, LLC7,650,0002026-03-31
Bleichroeder LP6,250,0002026-03-31
Vanguard Capital Management LLC881,6722026-03-31
Dsg Capital Advisors, LLC 625,0002026-03-31
Geode Capital Management, LLC521,8242026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADGM $0.38 +1.60% -0.56 $8.45M 0.00%
ADTX $0.01 -77.22% -0.01 $318 0.00%
ALURAllurion Technologies Inc. $4.72 -14.27% -0.08 $4.72M 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
CODX $2.04 -2.86% -0.11 $2.28M 0.00%

About COCH

COCH is led by CEO Brent T. Lucas, employs 42 people, headquartered in US, publicly traded since 2021.

COCH stock trades at $0.67 with a market capitalization of $14.02M. The stock is valued at a price-to-earnings (P/E) ratio of -0.74, price-to-book of 4.91, price-to-sales of 66.84. Over the past 52 weeks the stock has ranged between $0.36 and $1.89, and currently trades 64.6% below its 52-week high.

On profitability, COCH generates a return on equity (ROE) of 239.44% — well above the market average, a sign of a high-quality business, return on capital employed of -131.29%, an operating margin of 0.00%, a net profit margin of -98.76%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides